📰 Iagnostics News
Page 134 - Iagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.
June 12, 2021
Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting. By binding to activated fibroblasts present in affected lungs, FAPI-PET allows for direct imaging of the disease process.
June 11, 2021
Image: Illustration by Burnet PhD Student, Thorey Jonsdottir On Medical Research Week, we celebrate all researchers, students and the support...
June 11, 2021
2021 0611 NUS engineers devise novel approach to wirelessly power multiple wearable devices using a single source A team led by Associate Professor...
June 11, 2021
The collection of nasopharyngeal swab (NPS) samples for COVID-19 diagnostic testing poses challenges including exposure risk to healthcare workers and supply chain constraints. Saliva samples are easier to collect but can be mixed with mucus or blood, and some studies have found they produce less accurate results.
June 11, 2021
Brian Gray (patient) with Sarah Bowmer (Front) Lillie Biddlecombe (Back) at the Clinical Trials UnitThe first participants have taken part in a new...
June 11, 2021
The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP2D6 assays, promote standardization of testing across different laboratories and improve patient care
June 11, 2021
Member States at the High-Level Meeting on HIV and AIDS adopted a Political Declaration in order to get the world on track to end AIDS as a public health...
June 11, 2021
Paul Scully MP visited Scale Space this week, a new scale up community based at Imperial's White City Campus. Scale Space is the UK's first scale-up...
June 11, 2021
Preclinical trials of a new radiopharmaceutical to treat ovarian cancer have produced successful results, dramatically limiting tumor growth and decreasing tumor mass. Designed specifically for ovarian cancers that are resistant to traditional therapies, the new radiopharmaceutical can be produced in 25 minutes at low cost, which leads to better efficiency compared with alternative methods. This research was presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.
June 10, 2021
Despite knowing about decompression sickness - or the bends - for more than a century, researchers are still mystified about how this condition occurs. A new study published by the open access journal Frontiers is the first to explore the genetic changes that occur in humans with the bends. It reveals that genes involved in white blood cell activation and inflammation are upregulated in divers with this condition. The results may pave the way for tests that allow doctors to diagnose decompressio...